Skip to main content
. 2021 Jan 23;18(3):992. doi: 10.3390/ijerph18030992

Table 1.

Clinical characteristics of subjects according to smoking status.

NS p FS p CS p p-Value
(n = 90) NS vs. FS (n = 38) FS vs. CS (n = 48) NS vs. CS NS vs. FS vs. CS
Gender (male) 28 (33%) 0.010 21 (55%) 0.500 23 (48%) 0.051 0.020
Age (years) 43 ± 13 0.247 46 ± 11 0.985 46 ± 17 0.267 0.370
BMI (kg/m2) 27 ± 6 0.104 29 ± 6 0.363 28 ± 7 0.565 0.330
BMI n (%) 0.210 0.320 0.910 0.480
Normal 44 (49%) 11 (29%) 21 (44%)
Overweight 26 (29%) 14 (37%) 12 (25%)
Obese 20 (22%) 13 (34%) 15 (31%)
Family history n (%)
Asthma 17 (19%) 0.210 11 (29%) 0.300 19 (40%) 0.008 0.030
Atopy 15 (17%) 0.010 14 (37%) 0.730 16 (33%) 0.030 0.020
Personal atopy n (%) 40 (44%) 0.400 20 (53%) 0.110 17 (35%) 0.310 0.270
Number of pack-year 0 ± 0 <0.001 5.3 ± 7.2 0.372 14.4 ± 7.4 <0.001 0.004
Asthma onset n (%) 0.283 0.170 0.283 0.571
Childhood 28 (31%) 9 (24%) 21 (44%)
Adult 56 (62%) 29 (76%) 27 (56%)
Dyspnea
Presence n (%) 34 (38%) <0.001 27 (71%) 0.020 22 (46%) 0.360 0.003
Degree mMRC 1.4 ± 1.3 0.820 1.4 ± 1 0.179 1.9 ± 1.1 0.335 0.866
Asthma Control
Controlled n (%) 66 (73%) 0.045 21 (55%) 0.210 20 (42%) <0.001 0.001
ACQ score 1.2 ± 1.2 0.844 1.2 ± 1.1 0.019 1.9 ± 1.1 0.016 0.023
Exacerbations 0.110 0.004 <0.001 <0.001
No 70 (78%) 23 (61%) 21 (44%)
1 10 (11%) 9 (24%) 4 (8%)
≥2 10 (11%) 6 (16%) 23 (48%)
Exacerbations number/year 0.5 ± 0.1 0.195 0.6 ± 0.8 0.002 1.3 ± 0.2 <0.001 <0.001
Comorbidities
Anxiety trait 9 (10%) 0.040 9 (24%) 0.930 11 (23%) 0.040 0.060
Depression trait 3 (3%) 0.040 5 (13%) 0.270 3 (6%) 0.420 0.110
Treatment GINA steps 2 ± 1 0.581 2 ± 1 0.162 3 ± 1 0.029 0.120

Note: NS: never-smokers; FS: former-smokers; CS: current-smokers; BMI: body mass index; mMRC: Modified Medical Research Council scale; ACQ: Asthma Control Questionnaire; GINA: Global Initiative for Asthma guidelines. Data is shown as mean ± standard deviation (SD). Bold characters show the significant differences (p value < 0.05).